Molnupiravir
Study: Antiviral drugs reduce Covid death risk
The use of antiviral medications significantly lowers the risk of hospitalization and death caused by Covid-19 among older patients, according to a Greek study.
- Read more about Study: Antiviral drugs reduce Covid death risk
- Log in to post comments
WHO recommends the Pfizer Pill against COVID-19
The World Health Organization said yesterday that it "strongly recommends" Pfizer Paxlovid's antiviral pill against Covid-19 for patients with milder forms of the disease who are still at high risk of hospitalization.
- Read more about WHO recommends the Pfizer Pill against COVID-19
- Log in to post comments
Anti-Covid drug molnupiravir available from next week
Ljubljana – The anti-viral drug molnupiravir will be available for treatment of Covid-19 in Slovenia expectedly from Monday after doses for over 5,700 treatments have already arrived in the country. The medicine will be prescribed to adults, except pregnant women and breastfeeding mothers, who are likely to develop a severe form of Covid-19.
Medical ethics committee approves of anti-Covid drug Lagevrio
Ljubljana – Slovenia’s national medical ethics committee has no reservations towards Lagevrio, a medicine also known as molnupiravir. The committee maintains that the drug brings significant progress in fighting the coronavirus epidemic, as it prevents a severe course of Covid-19 or death.
The Anti-Covid “Merck” Pill turns out as not very Effective
Updated data from the experimental pill for the treatment of COVID-19 by the American company Merck & Co show that its effectiveness is significantly lower than the original report. According to preliminary data from October, "molnupiravir" reduces the risk of death and hospitalization by 50%.
Minister urges to ‘comply with pandemic conditions’
As Turkey's daily COVID-19 cases have been rising steadily in the past few weeks and lingering around 25,000 over the last couple of days, Turkish authorities continue to call on citizens to comply with pandemic measures.
Health Minister Fahrettin Koca once again called on the people to comply "with the conditions of the fight" against the pandemic.
Pfizer's Covid Drug May be Available in Early 2022
Pfizer UK managing director Ben Osborne said on Tuesday that the pharmaceutical company's Covid-19 drug, Paxlovid, could be available in the UK "very early in 2022".
Meanwhile, Merck's coronavirus pill, Molnupiravir, will be released as part of a UK trial in late November.
- Read more about Pfizer's Covid Drug May be Available in Early 2022
- Log in to post comments
Pfizer starts Testing Covid Prevention Pill
Pfizer announced today it has started a mid-to-late-stage study testing its oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to the virus, news wires reported. The company and its rivals, such as US-based Merck and Swiss Roche, have been racing to develop the first antiviral pill for Covid-19.
- Read more about Pfizer starts Testing Covid Prevention Pill
- Log in to post comments